The interaction between USP30 and ACLY leads to the deubiquitination of ACLY, resulting in the increased stability of ACLY, and thereby promoting adipogenesis, inflammation and tumorigenesis in hepatocellular carcinoma.41 The gene discussed is USP30; the disease is hepatocellular carcinoma.